These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28672959)

  • 41. Y-box-binding protein-1 expression is not correlated with p53 expression but with proliferating cell nuclear antigen expression in non-small cell lung cancer.
    Yoshimatsu T; Uramoto H; Oyama T; Yashima Y; Gu C; Morita M; Sugio K; Kohno K; Yasumoto K
    Anticancer Res; 2005; 25(5):3437-43. PubMed ID: 16101161
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ZEB1 promotes prostate cancer proliferation and invasion through ERK1/2 signaling pathway.
    Song XF; Chang H; Liang Q; Guo ZF; Wu JW
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4032-4038. PubMed ID: 29028100
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Propofol inhibits invasion and growth of ovarian cancer cells via regulating miR-9/NF-κB signal.
    Huang X; Teng Y; Yang H; Ma J
    Braz J Med Biol Res; 2016 Dec; 49(12):e5717. PubMed ID: 27982283
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 4-Hydroxybutenolide impairs cell migration, and invasion of human oral cancer SCC-4 cells via the inhibition of NF-κB and MAPK signaling pathways.
    Yu FS; Lin ML; Hsu SC; Yu CC; Huang YP; Kuo YH; Chung JG
    Int J Oncol; 2016 Aug; 49(2):579-88. PubMed ID: 27221634
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The antimicrobial peptide derived from insulin-like growth factor-binding protein 5, AMP-IBP5, regulates keratinocyte functions through Mas-related gene X receptors.
    Chieosilapatham P; Niyonsaba F; Kiatsurayanon C; Okumura K; Ikeda S; Ogawa H
    J Dermatol Sci; 2017 Oct; 88(1):117-125. PubMed ID: 28554590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
    Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
    Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy.
    Stratford AL; Habibi G; Astanehe A; Jiang H; Hu K; Park E; Shadeo A; Buys TP; Lam W; Pugh T; Marra M; Nielsen TO; Klinge U; Mertens PR; Aparicio S; Dunn SE
    Breast Cancer Res; 2007; 9(5):R61. PubMed ID: 17875215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Y-box binding protein-1 promotes castration-resistant prostate cancer growth via androgen receptor expression.
    Shiota M; Takeuchi A; Song Y; Yokomizo A; Kashiwagi E; Uchiumi T; Kuroiwa K; Tatsugami K; Fujimoto N; Oda Y; Naito S
    Endocr Relat Cancer; 2011 Aug; 18(4):505-17. PubMed ID: 21652770
    [TBL] [Abstract][Full Text] [Related]  

  • 51. YB-1 Mediates TNF-Induced Pro-Survival Signaling by Regulating NF-κB Activation.
    Shah A; Plaza-Sirvent C; Weinert S; Buchbinder JH; Lavrik IN; Mertens PR; Schmitz I; Lindquist JA
    Cancers (Basel); 2020 Aug; 12(8):. PubMed ID: 32764479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long non-coding RNA MALAT1 is up-regulated in ovarian cancer tissue and promotes SK-OV-3 cell proliferation and invasion.
    Zou A; Liu R; Wu X
    Neoplasma; 2016; 63(6):865-872. PubMed ID: 27565324
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear factor-kB signaling pathway constitutively activated in esophageal squamous cell carcinoma cell lines and inhibition of growth of cells by small interfering RNA.
    Tian F; Zang WD; Hou WH; Liu HT; Xue LX
    Acta Biochim Biophys Sin (Shanghai); 2006 May; 38(5):318-26. PubMed ID: 16680372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. EYA4 inhibits hepatocellular carcinoma growth and invasion by suppressing NF-κB-dependent RAP1 transactivation.
    Mo SJ; Hou X; Hao XY; Cai JP; Liu X; Chen W; Chen D; Yin XY
    Cancer Commun (Lond); 2018 Apr; 38(1):9. PubMed ID: 29764501
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Enhancing the anticancer efficacy of a LL-37 peptide fragment analog using peptide-linked PLGA conjugate micelles in tumor cells.
    Mori T; Hazekawa M; Yoshida M; Nishinakagawa T; Uchida T; Ishibashi D
    Int J Pharm; 2021 Sep; 606():120891. PubMed ID: 34324984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LL-37 Might Promote Local Invasion of Melanoma by Activating Melanoma Cells and Tumor-Associated Macrophages.
    Ohuchi K; Ikawa T; Amagai R; Takahashi T; Roh Y; Endo J; Kambayashi Y; Asano Y; Fujimura T
    Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980564
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antimicrobial peptide LL-37 participates in the transcriptional regulation of melanoma cells.
    Muñoz M; Craske M; Severino P; de Lima TM; Labhart P; Chammas R; Velasco IT; Machado MC; Egan B; Nakaya HI; Pinheiro da Silva F
    J Cancer; 2016; 7(15):2341-2345. PubMed ID: 27994673
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence that the Human Innate Immune Peptide LL-37 may be a Binding Partner of Amyloid-β and Inhibitor of Fibril Assembly.
    De Lorenzi E; Chiari M; Colombo R; Cretich M; Sola L; Vanna R; Gagni P; Bisceglia F; Morasso C; Lin JS; Lee M; McGeer PL; Barron AE
    J Alzheimers Dis; 2017; 59(4):1213-1226. PubMed ID: 28731438
    [TBL] [Abstract][Full Text] [Related]  

  • 59. C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?
    Pinger CW; Entwistle KE; Bell TM; Liu Y; Spence DM
    Mol Biosyst; 2017 Jul; 13(8):1432-1437. PubMed ID: 28685788
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aromaticity of Phenylalanine Residues Is Essential for Amyloid Formation by Alzheimer's Amyloid β-Peptide.
    Genji M; Yano Y; Hoshino M; Matsuzaki K
    Chem Pharm Bull (Tokyo); 2017; 65(7):668-673. PubMed ID: 28674340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.